Friday 6 November 2026 Export DSS’s income statement to Excel — free account

DSS, Inc.

DSS Consumer Cyclical Packaging & Containers

DSS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.8 million, up 8.69% from fiscal 2024.

Revenue: −31.8%
EPS: −100.0%
Free cash flow: −161.8%
Total debt: −33.4%

Quarter to June 2026, against a year earlier

0.46 0.07 −13.21%

Follow DSS

Alert me

Market cap: $4.6M
P/E: 0.0×
Fwd P/E: −0.4×
Dividend yield: —
F-score: 4/9
Altman Z: −7.67
Beneish M: n/a
Dividend safety: n/a

Overview

Insider Decisions last twelve months

Sold, $m 0.02

Trades a month
	Jan 26			Apr 26			Jul 26			Oct 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	1	—	—

Insider Ownership 59.67%

Capital & Financial Ratios $m

Size

Market Cap 4.62

Revenue ttm 18.45

Net income ttm (30.85)

Free cash flow ttm (4.82)

Net debt Q 31.99

Valuation

P/E 0.00

Forward P/E (0.37)

Price / sales 0.25

Forward P/S Powerpack

Price / FCF 0.00

Price / book 0.55

Financial health

Current ratio Q 0.19

Debt / equity Q 4.40

Interest coverage Q (42.54)

Growth

Revenue growth Q −31.81%

Operating income growth Q −10.54%

EPS, this year +48.12%

EPS, next year A +89.47%

Revenue, next year A −5.91%

EPS, past 5 yrs —

EPS, next 5 yrs A +44.86%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.84%

10-year low 10-year high

P/B against its own 10 years 52.11%

10-year low 10-year high

EV/Sales against its own 10 years 66.83%

10-year low 10-year high

Dividends

Yield: —
Annual rate: —
Payout ratio: —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	7	14	9	5
Receivables	4	3	2	1
Inventory	3	2	2	2
Other	52	45	—	—
	75	67	14	9

	2023	2024	2025	Q'26
Payables	4	3	3	3
ST’ Debt	48	50	31	32
Other	1	4	4	3
	56	65	47	49

Compound Annual Growth %

	10y	5y	3y
Sales	1.72%	6.20%	(9.90%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	8.98%	(35.25%)	(61.83%)

Earnings Trends EPS, adjusted, against the consensus

Q3 FY23 Estimate −0.20 Actual −0.60

−3.42 −2.51 −1.60 −0.69 0.22

Q3 FY22 Miss −1.80

Q1 FY23 Met 0.00

Q2 FY23 Miss −1.00

Q3 FY23 Miss −0.40

Earnings per share against the consensus, by quarter
Quarter	Estimate	Reported	Result
Q3 FY22	−1.20	−3.00	Miss by 1.80
Q1 FY23	−1.20	−1.20	Met by 0.00
Q2 FY23	−0.40	−1.40	Miss by 1.00
Q3 FY23	−0.20	−0.60	Miss by 0.40

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.60)	(0.48)	—	—	—
’25	(0.55)	(0.24)	(0.25)	(1.63)	(2.66)
’24	(0.58)	(0.66)	(0.75)	(4.64)	(6.63)
’23	(1.20)	(5.40)	(0.60)	(4.32)	(8.20)
’22	(2.00)	(3.10)	(3.00)	(3.59)	(10.72)
’21	(4.20)	(4.80)	(3.83)	(0.30)	(13.21)
’20	(24.60)	(7.60)	13.00	26.22	6.20

Fiscal quarters ending in the months shown.

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	4	4	—	—	—
’25	5	5	6	4	21
’24	4	4	6	5	19
’23	12	7	4	3	26
’22	12	12	12	(8)	28
’21	4	4	5	7	20
’20	4	3	4	5	15

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	0	(2)	—	—	—
’25	0	(1)	(7)	(2)	(9)
’24	(2)	(3)	(4)	0	(9)
’23	(14)	(6)	(1)	2	(19)
’22	(6)	(8)	(9)	(4)	(27)
’21	(8)	(2)	(2)	3	(9)
’20	(1)	(1)	(1)	(4)	(7)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	0	(2)	—	—	—
’25	10	(1)	(8)	5	6
’24	(2)	2	(4)	0	(3)
’23	(15)	(5)	(2)	2	(20)
’22	(5)	(8)	(10)	(5)	(28)
’21	(11)	(7)	(4)	(75)	(98)
’20	(1)	(1)	(1)	(4)	(7)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM Jun ’26	Trend	10 yrs	2026e	2027e	2028e	Next 3/yr
													Ten-year view		Analyst estimates Powerpack
Income, $m
Income, $m	Revenue	19	19	19	16	15	20	28	26	19	21	18		+0.9%	20	—	—	(5.9%)
	Gross margin, %	42.02	41.01	35.98	33.49	28.35	17.02	(16.24)	2.09	(23.26)	(10.45)	(20.86)		(52.5) pt	Powerpack DSS, Inc.’s next three years, line by line Analysts expect revenue to shrink 5.9% a year to 2028 — slower than the 0.9% of the last 9 years. See the consensus for every other line: earnings, margins, cash flow, valuation and returns. Unlock estimates Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time. Also in Powerpack: every quarter, Excel exports, API & MCP access. Compare plans
	EBT	(1)	(1)	1	(3)	0	(40)	(43)	(74)	(54)	(27)	(31)		+45.5%
	EBT margin, %	(4.90)	(3.21)	8.00	(17.49)	1.86	(198.28)	(150.57)	(285.50)	(281.19)	(132.43)	(167.49)		(127.5) pt
	Net income	(1)	(1)	1	(3)	2	(36)	(70)	(78)	(54)	(27)	(31)		+45.3%
Per share, $
Per share, $	Revenue	879.71	777.58	666.01	365.88	86.62	7.87	5.09	3.71	2.70	2.31	1.84		(48.3%)
	Earnings	(42.04)	(24.02)	54.05	(66.07)	10.80	(12.86)	(11.01)	(8.20)	(6.63)	(2.66)	(2.96)		(26.4%)
	Cash flow	250.76	(53.71)	(49.74)	(128.24)	(38.51)	(3.50)	(4.83)	(2.74)	(1.24)	(1.02)	(1.06)		n/m
	Capex	6.95	(40.43)	(39.69)	(30.99)	(1.81)	(34.62)	(0.17)	(0.08)	0.75	1.71	0.58		(14.4%)
	Free cash flow	257.70	(94.15)	(89.44)	(159.22)	(40.32)	(38.12)	(5.00)	(2.82)	(0.48)	0.70	(0.48)		(48.1%)
	Book value	150.65	199.41	272.46	289.48	431.48	76.93	28.07	11.89	4.63	0.97	0.84		(42.9%)
	Shares, m	0	0	0	0	0	3	6	7	7	9	9		+95.3%
Valuation, ×
Valuation, ×	P/E	0.00	0.00	6.83	0.00	11.20	0.00	0.00	0.00	0.00	0.00	0.00		1.8
	P/S	0.42	1.36	0.62	0.46	1.34	1.59	0.62	0.71	0.33	0.40	0.25		0.8
	P/B	2.45	5.30	1.50	0.58	0.27	0.16	0.11	0.22	0.19	0.96	0.55		1.2
	EV/Sales	0.44	1.27	0.61	0.57	1.15	1.74	2.33	2.85	2.32	1.74	1.98		1.5
	EV/FCF	1.50	(10.46)	(4.58)	(1.30)	(2.51)	(0.36)	(1.45)	(1.96)	(2.03)	(3.07)	(1.60)		(2.6)
Cash, $m
Cash, $m	Operating cash flow	5	(1)	(1)	(5)	(7)	(9)	(27)	(19)	(9)	(9)	(11)		n/m
	Capex	0	(1)	(1)	(1)	0	(89)	(1)	(1)	5	15	6		+67.1%
	Free cash flow	6	(2)	(2)	(7)	(7)	(98)	(28)	(20)	(3)	6	(5)		+1.2%
Balance, $m
Balance, $m	Working capital	2	(1)	1	3	4	52	(26)	19	2	(33)	(40)		n/m
	Net debt	0	(2)	0	2	(3)	3	49	56	38	28	32		+60.1%
	Shareholders’ equity	3	5	8	12	77	198	157	83	33	9	8		+11.5%
Returns, %
Returns, %	ROA	(5.58)	(3.22)	8.96	(16.31)	3.39	(17.68)	(22.51)	(30.15)	(36.12)	(27.49)	(34.14)		(21.9) pt
	ROIC	(11.19)	(4.64)	(14.12)	(11.72)	(9.70)	(7.31)	(9.13)	(22.87)	(37.72)	(24.74)	(25.59)		(13.5) pt
	ROE	(27.25)	(14.33)	23.71	(29.07)	4.27	(24.11)	(33.73)	(50.54)	(80.90)	(115.51)	(154.11)		(88.3) pt
People
People	Employees	104	98	106	100	93	113	119	95	100	102	—		(0.2%)
	Revenue/emp, $m	0.18	0.19	0.17	0.16	0.17	0.18	0.24	0.27	0.19	0.20	—		+1.1%

Negative figures in brackets.

estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
TRS TriMas Corporation	$1.4B	1.6×	— (loss-making)	+1.65% (above 0%: growing)	−9.76% (below 0%: shrinking)	−451.48% (below 0%: shrinking)	20.24%	6.22%	Compare
KRT Karat Packaging Inc.	$1.0B	20.5×	20.5×	+9.93% (above 0%: growing)	+167.27% (above 0%: growing)	+217.81% (above 0%: growing)	56.61%	27.59%	Compare
MYE Myers Industries, Inc.	$1.0B	35.7×	35.2×	+8.12% (above 0%: growing)	n/m	−48.52% (below 0%: shrinking)	27.30%	8.66%	Compare
OI O-I Glass, Inc.	$829.8M	— (loss-making)	— (loss-making)	−1.81% (below 0%: shrinking)	n/m	−17.21% (below 0%: shrinking)	12.01%	6.16%	Compare
ORBS Eightco Holdings Inc.	$301.4M	— (loss-making)	—	−72.71% (below 0%: shrinking)	n/m	−7,929.05% (below 0%: shrinking)	4.84%	(570.97%)	Compare
PACK Ranpak Holdings Corp	$286.5M	— (loss-making)	— (loss-making)	+2.31% (above 0%: growing)	n/m	+957.14% (above 0%: growing)	35.62%	0.00%	Compare
MGIH Millennium Group International Holdings Limited	$14.5M	—	—	—	—	+16.01% (above 0%: growing)	—	—	Compare
YHGJ Yunhong Green CTI Ltd.	$8.1M	— (loss-making)	— (loss-making)	−28.53% (below 0%: shrinking)	n/m	+218.01% (above 0%: growing)	13.79%	(8.21%)	Compare
DSS DSS, Inc.	$4.6M	— (loss-making)	— (loss-making)	−31.81% (below 0%: shrinking)	n/m	−161.76% (below 0%: shrinking)	(25.39%)	(105.05%)
Median of peers	$565.6M	20.5×	—	+1.65%	—	−0.60%	20.24%	6.16%

All 23 Packaging & Containers stocks →

DSS, Inc. (DSS) Latest News

16 Sep

Impact 4 · 4:26 PM · GlobeNewswire

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

Impact 3 · 9:25 AM

DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited

8 Sep

Impact 4 · 8:45 AM

DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations

4 Sep

Impact 4 · 10:27 AM

DSS Shares Crash After Soaring. What the New Offering Means for Investors

3 Sep

Impact 4 · 8:17 PM

DSS, Inc. Announces Launch of Proposed Public Offering

8 May

Impact 5 · 5:00 PM · GlobeNewswire

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

15 Apr

Impact 3 · 4:31 PM · GlobeNewswire

DSS, Inc. Letter to Shareholders

3 Feb

Impact 4 · 8:50 AM · GlobeNewswire

DSS, Inc. Issues Letter to Shareholders

Impact 3 · 8:17 PM · GlobeNewswire

DSS, Inc. Announces Launch of Proposed Public Offering

10 Jan

Impact 3 · 9:11 PM · Simply Wall St.

Do Its Financials Have Any Role To Play In Driving DS Sigma Holdings Berhad's (KLSE:DSS) Stock Up Recently?

30 Nov

Impact 3 · 11:53 PM

Investors Could Be Concerned With DS Sigma Holdings Berhad's (KLSE:DSS) Returns On Capital

18 Oct

Impact 3 · 8:50 PM · Simply Wall St.

Estimating The Intrinsic Value Of DS Sigma Holdings Berhad (KLSE:DSS)

31 Jul

Impact 3 · 8:35 PM

Should Weakness in DS Sigma Holdings Berhad's (KLSE:DSS) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

24 Jun

Impact 4 · 8:30 AM

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger

22 May

Impact 4 · 8:31 AM · GlobeNewswire

DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth

24 Apr

Impact 4 · 8:30 AM

Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings

26 Feb

Impact 3 · 8:30 AM · GlobeNewswire

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

10 Sep

Impact 3 · 9:00 AM · GlobeNewswire

AmericaFirst Funds Trust Announces Changes to Board of Trustees

26 Aug

Impact 4 · 4:08 PM · GlobeNewswire

DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

30 Jan

Impact 4 · 8:05 AM · GlobeNewswire

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

4 Jan

Impact 4 · 8:15 AM · GlobeNewswire

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

22 Dec

Impact 4 · 4:30 PM · GlobeNewswire

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

28 Nov

Impact 4 · 8:10 AM · GlobeNewswire

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Impact 3 · 9:12 AM · Zacks Small Cap Research

DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction

15 Nov

Impact 4 · 1:57 PM · GlobeNewswire

Impact Biomedical Inc. Files Current Report on Form 8-K

14 Nov

Impact 4 · 8:00 AM · GlobeNewswire

DSS Inc. Wins Patent Dispute with Nichia Corporation

8 Nov

Impact 3 · 8:31 AM · GlobeNewswire

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock

26 Oct

Impact 3 · 5:25 PM · GlobeNewswire

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

23 Oct

Impact 4 · 8:25 AM · GlobeNewswire

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

12 Oct

Impact 4 · 8:25 AM · GlobeNewswire

DSS Inc. Issues Letter to Shareholders

Insider Decisions last twelve months

Capital & Financial Ratios $m

Valuation vs history

Dividends

Assets vs Liabilities $m

Compound Annual Growth %

Earnings Trends EPS, adjusted, against the consensus

EPS $

Revenue $m

Operating Cash Flow $m

Free Cash Flow $m

Target Price Range

Recommendation Rating

Ten years at a glance Fiscal years to December

DSS, Inc. vs peers in Packaging & Containers (Q) = latest quarter vs a year earlier

DSS, Inc. (DSS) Latest News

16 Sep

8 Sep

4 Sep

3 Sep

8 May

15 Apr

3 Feb

10 Jan

30 Nov

18 Oct

31 Jul

24 Jun

22 May

24 Apr

26 Feb

10 Sep

26 Aug

30 Jan

4 Jan

22 Dec

28 Nov

15 Nov

14 Nov

8 Nov

26 Oct

23 Oct

12 Oct

Stockrow Weekly